Paolo Pontoniere

An interview with MIT biologist David Sun Kong—on science, activism, and how biotechnology can empower ordinary people.

Demand from body builders, neonatal intensive care units, and Big Pharma fuels synbio substitutions for the goodness of breast milk.

What your doormat, body odor, or wandering gaze can tell us that we don’t already know.

Major corporations are applying the lessons of cognitive neuroscience to get the American public buying.

Next-generation wearable sensors will combine biochemical and physiological metrics.

iAge, an inflammation aging clock, aims to predict your risk of disease and death.